Journal article

Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey

David Hammond, Jessica L Reid, Pete Driezen, K Michael Cummings, Ron Borland, Geoffrey T Fong, Ann McNeill

Addiction | WILEY | Published : 2008

Abstract

AIMS: To measure the prevalence and correlates of nicotine replacement therapy (NRT) use for reasons other than quitting smoking among smokers in four countries. DESIGN AND SETTING: Population-based, cross-sectional telephone survey with nationally representative samples of adult smokers in Canada, the United States, the United Kingdom and Australia, conducted in 2005. PARTICIPANTS: A total of 6532 adult daily smokers in Canada (n = 1660), the United States (n = 1664), the United Kingdom (n = 1617) and Australia (n = 1591). MEASUREMENTS: Survey questions included demographics, smoking behaviour, use of NRT and reasons for NRT use, as well as access and availability of NRT. FINDINGS: Approxim..

View full abstract

Grants

Awarded by National Cancer Institute of the United States


Awarded by Roswell Park Transdisciplinary Tobacco Use Research Center


Awarded by Robert Wood Johnson Foundation


Awarded by Canadian Institutes of Health Research


Awarded by National Health and Medical Research Council of Australia


Awarded by Cancer Research UK


Awarded by Canadian Tobacco Control Research Initiative


Awarded by Economic and Social Research Council


Funding Acknowledgements

This research was funded by grants from the National Cancer Institute of the United States ( through R01 CA 100362 and through the Roswell Park Transdisciplinary Tobacco Use Research Center, P50 CA111236), the Robert Wood Johnson Foundation ( 045734), the Canadian Institutes of Health Research ( 57897), the National Health and Medical Research Council of Australia ( 265903), Cancer Research UK (C312/A3726) and the Canadian Tobacco Control Research Initiative ( 014578), with additional support from the Centre for Behavioural Research and Program Evaluation, National Cancer Institute of Canada/Canadian Cancer Society.